Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 07, 2026
WisdomTree Europe Defense Fund (WDEF): Exposure to Europe's Rearmament Cycle

WisdomTree Europe Defense Fund (WDEF): Exposure to Europe's Rearmament Cycle

Key Takeaways

  • WDEF provides pure-play exposure to European defense companies, tracking a tier-weighted index of firms deriving at least 10% of revenue from defense-related activities.
  • The ETF is heavily concentrated in Industrials (~94%) with top holdings including Thales, BAE Systems, and Rheinmetall AG, reflecting France, the UK, and Germany accounting for over 70% of country exposure.
  • Europe is navigating its largest rearmament cycle since the Cold War, driven by NATO spending commitments, the war in Ukraine, and uncertainty around long-term U.S. security guarantees.
  • The fund has experienced elevated volatility in recent months, with a notable V-shaped recovery as defense budgets translate into concrete procurement contracts and industrial consolidation accelerates.
  • Key risks include execution challenges in scaling production capacity, political fragmentation over budget priorities, and potential shifts in transatlantic defense procurement dynamics.

WisdomTree Europe Defense Fund (WDEF) Overview

The WisdomTree Europe Defense Fund (WDEF) is a passively managed exchange-traded fund listed on the NYSE Arca that seeks to track the price and yield performance, before fees and expenses, of the WisdomTree Europe Defense Index. Launched in July 2025 with an expense ratio of 0.45%, the fund provides targeted exposure to European-listed companies with meaningful defense industry revenue.

The index employs a tier-weighted methodology: only companies deriving at least 10% of their revenue from defense-related activities qualify for inclusion, and constituents are weighted based on their degree of defense exposure. This construction ensures the fund remains anchored in pure-play defense names rather than diluted by conglomerates with marginal military revenue. As of mid-2026, WDEF held approximately 43 securities with total net assets around $94 million. The portfolio is overwhelmingly weighted toward Industrials, which account for roughly 94% of holdings, with minor allocations to Technology and Communication Services. I also checked this using Tickeron’s AI Screener to see how the holdings align with broader industry peers.

The top 10 holdings represent roughly 64% of the portfolio. Largest positions include Thales S.A. (approximately 10.5%), BAE Systems PLC (10.1%), Rheinmetall AG (9.9%), Leonardo S.p.A. (5.5%), Saab AB (5.3%), Kongsberg Gruppen ASA (4.9%), Hensoldt AG (4.7%), Airbus SE (4.6%), Dassault Aviation (4.5%), and Safran SA (4.4%). France, the United Kingdom, and Germany together represent more than 70% of country exposure, with Italy, Sweden, Norway, and Spain comprising most of the remainder.

Europe's Defense Sector Transformation

The European defense sector is undergoing a structural transformation without modern precedent. NATO's European members and Canada raised defense spending by approximately 20% in real terms during 2025, bringing combined expenditure to roughly $574 billion. For the first time since the 2%-of-GDP benchmark was established in 2014, every NATO ally met that target. At the 2025 Hague summit, allies went further, committing to 3.5% of GDP on core defense and an additional 1.5% on defense-adjacent spending by 2035. The July 2026 Ankara summit reinforced these commitments, with over $50 billion in new defense industry contracts announced.

Several reinforcing dynamics underpin this spending surge. Russia's war in Ukraine has exposed critical capability gaps across European militaries, from ammunition stockpiles to integrated air defense systems. Simultaneously, the Trump administration's repeated signals that Europe must assume primary responsibility for its own continental defense — including a six-month review of U.S. force posture in Europe — have accelerated the push for strategic autonomy. This is no longer a theoretical debate: it is translating into multi-year procurement programs, industrial consolidation, and a political consensus that spans major European economies.

The industrial landscape is also reshaping through mergers and acquisitions (M&A). Thales signed a binding agreement in July 2026 to acquire a controlling stake in Exail Technologies, while Germany's TKMS was selected for Canada's largest-ever defense procurement. These transactions illustrate how the sector is consolidating around a smaller number of increasingly capable European primes.

Recent Performance and Positioning

WDEF has experienced considerable volatility in recent months, consistent with a concentrated thematic fund operating in a geopolitically sensitive sector. After trading near $29.89 in early June 2026, the fund declined through late June to approximately $26.36 — a pullback of roughly 12% in under four weeks — as broader market uncertainty and profit-taking following a strong earlier rally weighed on defense names. The ETF then staged a pronounced recovery, rebounding to around $31.93 by early August, reflecting a gain of over 9% from late-June lows.

The recovery aligned with a series of catalysts: the Ankara NATO summit in early July produced concrete contract announcements and industrial cooperation agreements; several major holdings reported strong order intake; and defense M&A activity reinforced the structural growth narrative. The fund's heavy weighting in Rheinmetall AG, Thales, and BAE Systems means performance is particularly sensitive to order book announcements, government budget approvals, and geopolitical headlines involving European security. The V-shaped recovery pattern underscores both the sector's sensitivity to policy catalysts and the conviction among investors that Europe's rearmament cycle has durable political underpinnings. From what I see, this pattern is worth monitoring closely with tools like Tickeron’s AI Trend Prediction Engine for additional context on momentum shifts.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape WDEF's trajectory through the remainder of 2026. First, the translation of budget commitments into procurement contracts remains the central variable. Europe's defense spending pledges are unprecedented, but the institutional machinery governing expenditure — fragmented national procurement systems, varying industrial policies, and political horse-trading — can slow the pace at which orders convert into revenue for the companies WDEF holds.

Second, production capacity constraints represent a genuine bottleneck. Many European defense contractors operate at limited scale relative to U.S. peers, and lead times for artillery shells, armored vehicles, and air defense interceptors extend into years. Companies that demonstrate the ability to scale production efficiently are likely to capture disproportionate contract value. Third, the evolving transatlantic procurement dynamic warrants close attention. While the EU aims for members to source at least 60% of procurement within the bloc by 2035, near-term capability gaps — particularly in missile defense, intelligence, and long-range strike — may continue to favor U.S. suppliers, creating tension between strategic autonomy goals and operational urgency.

Macroeconomic conditions, including European interest rate trajectories and fiscal sustainability debates, could influence defense budget execution if economic growth disappoints. Additionally, any diplomatic breakthroughs regarding the Ukraine conflict or NATO-Russia relations could alter the perceived urgency of rearmament, though the structural underinvestment gap and the multi-year nature of existing procurement programs provide a degree of insulation against short-term shifts in sentiment. Investors should also monitor the fund's relatively small AUM and non-diversified structure, which can amplify both upside participation and downside risk relative to broader market ETFs. I’m watching this closely as order flow data continues to come in.

Using Tickeron’s AI Screener for Defense Sector Ideas

Investors seeking to identify opportunities within the European defense sector or across other thematic and industry exposures can leverage Tickeron’s AI Screener. This AI-powered discovery platform enables users to scan thousands of stocks and ETFs using a broad array of criteria, including technical indicators, fundamental metrics, volatility profiles, AI-generated trading signals, price patterns, and industry classifications. The screener is designed to surface securities matching specific investment themes, highlight breakout candidates, and filter for momentum or value characteristics far more efficiently than manual screening. In my view, it serves as a practical complement when evaluating concentrated thematic funds like WDEF alongside broader market options.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WDEF

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


WDEF in upward trend: price rose above 50-day moving average on July 22, 2026

WDEF moved above its 50-day moving average on July 22, 2026 date and that indicates a change from a downward trend to an upward trend. In of 9 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 23, 2026. You may want to consider a long position or call options on WDEF as a result. In of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for WDEF just turned positive on July 21, 2026. Looking at past instances where WDEF's MACD turned positive, the stock continued to rise in of 6 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for WDEF crossed bullishly above the 50-day moving average on July 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WDEF advanced for three days, in of 65 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 33 cases where WDEF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WDEF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WDEF broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Antero Midstream Corp (NYSE:AM).

Industry description

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree Europe Defense Index. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in constituents of the index and/or investments that have economic characteristics that are substantially similar to the economic characteristics of such constituents. The index provides exposure to common stock of European companies focused on the defense industry. The fund is non-diversified.

High and low price notable news

The average weekly price growth across all stocks in the WisdomTree Europe Defense Fund ETF was 2%. For the same ETF, the average monthly price growth was 7%, and the average quarterly price growth was 26%. AIR experienced the highest price growth at 5%, while AM experienced the biggest fall at -0%.
View a ticker or compare two or three
WDEF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Industrials

Profile
Details
Category
Industrials
Address
WisdomTree Trust380 Madison AveNew York
Phone
866-909-9473
Web
www.wisdomtree.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
WisdomTree Europe Defense Fund (WDEF): Exposure to Europe's Rearmament Cycle